-
-
-
-
-
-
-
Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Mersana Therapeutics (MRSN) Tops Q4 EPS by 4c
-
-
-
-
-
-
-
Mersana Therapeutics (MRSN) Misses Q2 EPS by 3c
-
-
-
-
-
-
-
Mersana Therapeutics (MRSN) Tops Q4 EPS by 5c
-
-
-
-
-
-
-
Mersana Therapeutics (MRSN) Misses Q1 EPS by 9c
-
-
-
-
-
-
-
Mersana Therapeutics to Host Third Quarter 2022 Conference Call on November 7, 2022
-
-
-
-
-
-
-
Mersana Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

